• PedNutritionExchange provides information and access to resources for the following products from Mead Johnson Nutrition:

  • Enfamil Infant
    • Enfamil® Infant

      Enfamil® Infant

      Enfamil Infant is a milk-based, iron-fortified formula for full-term infants 0–12 months.

      Enfamil Infant offers proven* clinical outcomes in 3 key areas: growth, brain and eye, and immune system development.

    • Product Features


      • A Neuro Complete blend of nutrients such as DHA that is also in breast milk
      • Has a DHA and ARA blend shown* to foster a child’s learning ability up to age 5
      • Clinically shown to improve long-term cognitive outcomes through 5 years of age vs Enfamil® without DHA*
      • Milk-based infant formula inspired by mature breast milk
      • A dual prebiotics blend—GOS (galactooligosaccharides) and polydextrose—to support the growth of beneficial gut bacteria, which emerging science suggests can help support the immune system
      • DHA to support mental, visual, and immune system development
      • Clinically shown to have a bifidogenic effect similar to that of breast milk4 in infants fed the formula between 30 and 90 days of age
      • Proven to improve* respiratory health through the first 3 years of life when infants were fed Enfamil Infant through 12 months
      • Clinically proven* growth similar to breastfed infants through 12 months, IQ scores and vision similar to breastfed infants up to 4 years of age, and support for the immune system
      • Easy-to-digest 60:40 whey-to-casein ratio, patterned after mature breast milk,

      * Studies compared infants fed Enfamil with DHA and ARA vs discontinued Enfamil without DHA and ARA; studied before the addition of prebiotics.

      Comparison based on whey:casein ratio of typical mature breast milk (15 days to 6 months after birth).

  • Enfamil A.R.
    • Enfamil A.R.

      Enfamil A.R. TM

      Enfamil A.R. is clinically proven to reduce frequent regurgitation and meets the reflux reduction guidance of the American Academy of Pediatrics.

      Long-Term Usage

      Enfamil A.R. is designed to provide a sole source of nutrition for infants up to age 6 months, and provide a major source of nutrition until 12 months.

    • Product Features


      • Proven* in a published, randomized, controlled trial (N=104) to reduce frequency and volume of regurgitation by more than 50%
      • Meets the reflux reduction guidance of the American Academy of Pediatrics
      • Nutritionally balanced with a caloric density and nutrient profile similar to routine infant formula, unlike adding rice cereal to formula
      • Thickens further when introduced into an acidic environment like the stomach, not in the bottle like rice cereal, so Enfamil A.R. flows freely through most standard nipples.
      • Blend of prebiotics to help support digestive health
      • A Neuro Complete blend of nutrients such as DHA that is also in breast milk
      • Has a DHA and ARA blend shown to foster a child’s learning ability up to age 5

      * Based on a published, double-blind, randomized, controlled trial of Enfamil A.R. with infants who spit up frequently (5 or more spit-ups per day) comparing frequency and volume of spit-up after feeding Enfamil A.R. to the same infants at the beginning of the study.

      Shown in Enfamil® Infant with DHA and ARA.

  • Nutramigen with Enflora LGG
    • Nutramigen with Enflora LGG

      Nutramigen® with Enflora™ LGG®*

      Nutramigen with Enflora LGG is an iron-fortified, galactose-free, hypoallergenic infant formula designed for newborns and infants who are allergic to the intact proteins in cow’s milk and soy formulas, as well as other foods. Nutramigen with Enflora LGG contains extensively hydrolyzed protein to avoid an immune system response by reducing the allergen exposure, and the probiotic LGG to help support the strength of the intestinal barrier and support digestive health. Nutramigen with Enflora LGG is also appropriate for infants with galactosemia.

      Long-Term Usage

      Extended use of Nutramigen with Enflora LGG (or other infant formulas) as a sole source of diet is most appropriately monitored by physicians and nutritionists on a case-by-case basis, with attention to developmental as well as nutritional implications of such a dietary regimen.

    • Product Features


      • Hypoallergenic, galactose-free and suitable for someone with lactose intolerance
      • Clinically proven to manage colic due to cow’s milk protein allergy fast—often within 48 hours1,2,†
      • Nutritionally complete
      • Contains the probiotic LGG to help support the strength of the intestinal barrier and support digestive health
      • Has DHA and ARA, important nutrients also found in breast milk, that promote brain and eye development3-10
      • Clinically proven in over 70 clinical studies
      • Has been demonstrated in two clinical trials to help infants build tolerance after 12 months of feeding11,12
      • Proven to promote skin health in infants through 18 months of age13,†
      • Proven to promote gastrointestinal (GI) health within 1 week of use14,†

      * LGG is a registered trademark of Valio Ltd. † Some studies were prior to the addition of DHA, ARA and LGG.


      References 1. Lothe L, Lindberg T, Jakobsson I. Cow’s milk formula as a cause of infantile colic: a double-blind study. Pediatrics. 1982;70:7-10. 2. Lothe L, Lindberg T. Cow’s milk whey protein elicits symptoms of infantile colic in colicky formula-fed infants: a double-blind crossover study. Pediatrics. 1989;83:262-266. 3. Birch EE, Hoffman DR, Uauy R, et al. Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. Pediatr Res. 1998;44:201-209. 4. Birch EE, Garfield S, Hoffman DR, et al. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol. 2000;42:174-181. 5. Birch EE, Hoffman DR, Castañeda YS, et al. A randomized controlled trial of long-chain polyunsaturated fatty acid supplementation of formula in term infants after weaning at 6 wk of age. Am J Clin Nutr. 2002;75:570-580. 6. Hoffman DR, Birch EE, Castañeda YS, et al. Visual function in breast-fed term infants weaned to formula with or without long-chain polyunsaturates at 4 to 6 months: a randomized clinical trial. J Pediatr. 2003;142:669-677. 7. Hoffman DR, Birch EE, Castañeda YS, et al. Maturation of visual and mental function in 18-month old infants receiving dietary long-chain polyunsaturated fatty acids (LCPUFAs) [abstract]. FASEB J. 2003;17:A727-A728. Abstract 445.1. 8. Hoffman DR, Birch EE, Birch DG, et al. Impact of early dietary intake and blood lipid composition of long-chain polyunsaturated fatty acids on later visual development. J Pediatr Gastroenterol Nutr. 2000;31:540-553. 9. Birch EE, Castañeda YS, Wheaton DH, et al. Visual maturation of term infants fed long-chain polyunsaturated fatty acid-supplemented or control formula for 12 mo. Am J Clin Nutr. 2005;81:871-879. 10. Morale SE, Hoffman DR, Castañeda YS, et al. Duration of long-chain polyunsaturated fatty acids availability in the diet and visual acuity. Early Hum Dev. 2005;81:197-203. 11. Canani R, Nocerino R, Terrin G, et al. Effect of Lactobacillus GG on tolerance acquisition in infants with cow’s milk allergy: a randomized trial. J Allergy Clin Immunol. 2012;129:580-582, 582 el-5. 12. Berni Canani R, Nocerino R, Terrin G, et al. Formula selection for management of children with cow’s milk allergy influences the rate of acquisition of tolerance: a prospective multicenter study. J Pediatr. 2013;163:771-777 el.

  • PurAmino
    • PurAmino

      PurAminoTM

      PurAmino is an iron-fortified, hypoallergenic, amino acid-based infant and toddler formula for the dietary management of infants and toddlers with severe cow's milk protein allergy, not effectively managed by an extensively hydrolyzed formula. PurAmino is also indicated for the dietary management of infants and toddlers with multiple food protein allergies. It may also be suitable for conditions requiring an elemental diet such as protein maldigestion, malabsorption, short bowel syndrome, and eosinophilic esophagitis.

    • Long-Term Usage

      PurAmino is designed to provide a sole source of nutrition for infants up to age 6 months and provide a major source of nutrition through 24 months of age, when indicated. Normally, in feeding infants, gradual introduction of solid foods after 4–6 months of age is an important developmental as well as nutritional step. In cases of severe and multiple food allergies or intolerances, PurAmino is sometimes continued as a milk substitute in the diet of children. This and similar supplemental use of PurAmino in the diet beyond 24 months of age may make a significant contribution to maintenance of good nutrition in such patients.

      When PurAmino is used as a milk substitute, the total calcium content of the diet should be assessed.

      Extended use of PurAmino (or other infant formulas) as a sole source of diet is most appropriately monitored by physicians and nutritionists on a case-by-case basis, with attention to developmental as well as nutritional implications of such a dietary regimen.

      Product Features

      • Hypoallergenic, iron-fortified
      • Nutritionally complete;
      • Can be sole source of nutrition up to age 6 months
      • Can be major source of nutrition through 24 months
      • Dietary reference intakes include a recommendation for fiber for >12 months of age
      • DHA and ARA, important nutrients also found in breast milk, that promotes brain and eye development
      • 2.8 g protein equivalent/100 Calories